questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Anticorps : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anticorps : Questions médicales les plus fréquentes",
"headline": "Anticorps : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anticorps : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-30",
"dateModified": "2025-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anticorps"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Immunoglobulines",
"url": "https://questionsmedicales.fr/mesh/D007136",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines",
"code": {
"@type": "MedicalCode",
"code": "D007136",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-idiotypiques",
"alternateName": "Antibodies, Anti-Idiotypic",
"url": "https://questionsmedicales.fr/mesh/D000888",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-idiotypiques",
"code": {
"@type": "MedicalCode",
"code": "D000888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.071"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-archéens",
"alternateName": "Antibodies, Archaeal",
"url": "https://questionsmedicales.fr/mesh/D019844",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-archéens",
"code": {
"@type": "MedicalCode",
"code": "D019844",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.107"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antibactériens",
"alternateName": "Antibodies, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D000907",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antibactériens",
"code": {
"@type": "MedicalCode",
"code": "D000907",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.125"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antistreptolysine",
"alternateName": "Antistreptolysin",
"url": "https://questionsmedicales.fr/mesh/D000989",
"about": {
"@type": "MedicalCondition",
"name": "Antistreptolysine",
"code": {
"@type": "MedicalCode",
"code": "D000989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.125.288"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps bispécifiques",
"alternateName": "Antibodies, Bispecific",
"url": "https://questionsmedicales.fr/mesh/D018033",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps bispécifiques",
"code": {
"@type": "MedicalCode",
"code": "D018033",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.134"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps bloquants",
"alternateName": "Antibodies, Blocking",
"url": "https://questionsmedicales.fr/mesh/D019138",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps bloquants",
"code": {
"@type": "MedicalCode",
"code": "D019138",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.143"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps catalytiques",
"alternateName": "Antibodies, Catalytic",
"url": "https://questionsmedicales.fr/mesh/D017151",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps catalytiques",
"code": {
"@type": "MedicalCode",
"code": "D017151",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.167"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antifongiques",
"alternateName": "Antibodies, Fungal",
"url": "https://questionsmedicales.fr/mesh/D000908",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antifongiques",
"code": {
"@type": "MedicalCode",
"code": "D000908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.179"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antihelminthe",
"alternateName": "Antibodies, Helminth",
"url": "https://questionsmedicales.fr/mesh/D000909",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antihelminthe",
"code": {
"@type": "MedicalCode",
"code": "D000909",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.185"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps hétérophiles",
"alternateName": "Antibodies, Heterophile",
"url": "https://questionsmedicales.fr/mesh/D000910",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps hétérophiles",
"code": {
"@type": "MedicalCode",
"code": "D000910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.191"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps monoclonaux",
"alternateName": "Antibodies, Monoclonal",
"url": "https://questionsmedicales.fr/mesh/D000911",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps monoclonaux",
"code": {
"@type": "MedicalCode",
"code": "D000911",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps monoclonaux humanisés",
"alternateName": "Antibodies, Monoclonal, Humanized",
"url": "https://questionsmedicales.fr/mesh/D061067",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps monoclonaux humanisés",
"code": {
"@type": "MedicalCode",
"code": "D061067",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adalimumab",
"alternateName": "Adalimumab",
"url": "https://questionsmedicales.fr/mesh/D000068879",
"about": {
"@type": "MedicalCondition",
"name": "Adalimumab",
"code": {
"@type": "MedicalCode",
"code": "D000068879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Alemtuzumab",
"alternateName": "Alemtuzumab",
"url": "https://questionsmedicales.fr/mesh/D000074323",
"about": {
"@type": "MedicalCondition",
"name": "Alemtuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000074323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Basiliximab",
"alternateName": "Basiliximab",
"url": "https://questionsmedicales.fr/mesh/D000077552",
"about": {
"@type": "MedicalCondition",
"name": "Basiliximab",
"code": {
"@type": "MedicalCode",
"code": "D000077552",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.407"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bévacizumab",
"alternateName": "Bevacizumab",
"url": "https://questionsmedicales.fr/mesh/D000068258",
"about": {
"@type": "MedicalCondition",
"name": "Bévacizumab",
"code": {
"@type": "MedicalCode",
"code": "D000068258",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Brentuximab védotine",
"alternateName": "Brentuximab Vedotin",
"url": "https://questionsmedicales.fr/mesh/D000079963",
"about": {
"@type": "MedicalCondition",
"name": "Brentuximab védotine",
"code": {
"@type": "MedicalCode",
"code": "D000079963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.469"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cétuximab",
"alternateName": "Cetuximab",
"url": "https://questionsmedicales.fr/mesh/D000068818",
"about": {
"@type": "MedicalCondition",
"name": "Cétuximab",
"code": {
"@type": "MedicalCode",
"code": "D000068818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Daclizumab",
"alternateName": "Daclizumab",
"url": "https://questionsmedicales.fr/mesh/D000077561",
"about": {
"@type": "MedicalCondition",
"name": "Daclizumab",
"code": {
"@type": "MedicalCode",
"code": "D000077561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.766"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dénosumab",
"alternateName": "Denosumab",
"url": "https://questionsmedicales.fr/mesh/D000069448",
"about": {
"@type": "MedicalCondition",
"name": "Dénosumab",
"code": {
"@type": "MedicalCode",
"code": "D000069448",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.782"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gemtuzumab",
"alternateName": "Gemtuzumab",
"url": "https://questionsmedicales.fr/mesh/D000079982",
"about": {
"@type": "MedicalCondition",
"name": "Gemtuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000079982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inotuzumab ozogamicine",
"alternateName": "Inotuzumab Ozogamicin",
"url": "https://questionsmedicales.fr/mesh/D000080045",
"about": {
"@type": "MedicalCondition",
"name": "Inotuzumab ozogamicine",
"code": {
"@type": "MedicalCode",
"code": "D000080045",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.794"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ipilimumab",
"alternateName": "Ipilimumab",
"url": "https://questionsmedicales.fr/mesh/D000074324",
"about": {
"@type": "MedicalCondition",
"name": "Ipilimumab",
"code": {
"@type": "MedicalCode",
"code": "D000074324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.798"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Natalizumab",
"alternateName": "Natalizumab",
"url": "https://questionsmedicales.fr/mesh/D000069442",
"about": {
"@type": "MedicalCondition",
"name": "Natalizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nivolumab",
"alternateName": "Nivolumab",
"url": "https://questionsmedicales.fr/mesh/D000077594",
"about": {
"@type": "MedicalCondition",
"name": "Nivolumab",
"code": {
"@type": "MedicalCode",
"code": "D000077594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.829"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Omalizumab",
"alternateName": "Omalizumab",
"url": "https://questionsmedicales.fr/mesh/D000069444",
"about": {
"@type": "MedicalCondition",
"name": "Omalizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069444",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Palivizumab",
"alternateName": "Palivizumab",
"url": "https://questionsmedicales.fr/mesh/D000069455",
"about": {
"@type": "MedicalCondition",
"name": "Palivizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069455",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Panitumumab",
"alternateName": "Panitumumab",
"url": "https://questionsmedicales.fr/mesh/D000077544",
"about": {
"@type": "MedicalCondition",
"name": "Panitumumab",
"code": {
"@type": "MedicalCode",
"code": "D000077544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.864"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ranibizumab",
"alternateName": "Ranibizumab",
"url": "https://questionsmedicales.fr/mesh/D000069579",
"about": {
"@type": "MedicalCondition",
"name": "Ranibizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.868"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trastuzumab",
"alternateName": "Trastuzumab",
"url": "https://questionsmedicales.fr/mesh/D000068878",
"about": {
"@type": "MedicalCondition",
"name": "Trastuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000068878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ado-trastuzumab emtansine",
"alternateName": "Ado-Trastuzumab Emtansine",
"url": "https://questionsmedicales.fr/mesh/D000080044",
"about": {
"@type": "MedicalCondition",
"name": "Ado-trastuzumab emtansine",
"code": {
"@type": "MedicalCode",
"code": "D000080044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ado-trastuzumab emtansine",
"alternateName": "Ado-Trastuzumab Emtansine",
"url": "https://questionsmedicales.fr/mesh/D000080044",
"about": {
"@type": "MedicalCondition",
"name": "Ado-trastuzumab emtansine",
"code": {
"@type": "MedicalCode",
"code": "D000080044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ustékinumab",
"alternateName": "Ustekinumab",
"url": "https://questionsmedicales.fr/mesh/D000069549",
"about": {
"@type": "MedicalCondition",
"name": "Ustékinumab",
"code": {
"@type": "MedicalCode",
"code": "D000069549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.937"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Adalimumab",
"alternateName": "Adalimumab",
"url": "https://questionsmedicales.fr/mesh/D000068879",
"about": {
"@type": "MedicalCondition",
"name": "Adalimumab",
"code": {
"@type": "MedicalCode",
"code": "D000068879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Alemtuzumab",
"alternateName": "Alemtuzumab",
"url": "https://questionsmedicales.fr/mesh/D000074323",
"about": {
"@type": "MedicalCondition",
"name": "Alemtuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000074323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Basiliximab",
"alternateName": "Basiliximab",
"url": "https://questionsmedicales.fr/mesh/D000077552",
"about": {
"@type": "MedicalCondition",
"name": "Basiliximab",
"code": {
"@type": "MedicalCode",
"code": "D000077552",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.407"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bévacizumab",
"alternateName": "Bevacizumab",
"url": "https://questionsmedicales.fr/mesh/D000068258",
"about": {
"@type": "MedicalCondition",
"name": "Bévacizumab",
"code": {
"@type": "MedicalCode",
"code": "D000068258",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Brentuximab védotine",
"alternateName": "Brentuximab Vedotin",
"url": "https://questionsmedicales.fr/mesh/D000079963",
"about": {
"@type": "MedicalCondition",
"name": "Brentuximab védotine",
"code": {
"@type": "MedicalCode",
"code": "D000079963",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.469"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cétuximab",
"alternateName": "Cetuximab",
"url": "https://questionsmedicales.fr/mesh/D000068818",
"about": {
"@type": "MedicalCondition",
"name": "Cétuximab",
"code": {
"@type": "MedicalCode",
"code": "D000068818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Daclizumab",
"alternateName": "Daclizumab",
"url": "https://questionsmedicales.fr/mesh/D000077561",
"about": {
"@type": "MedicalCondition",
"name": "Daclizumab",
"code": {
"@type": "MedicalCode",
"code": "D000077561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.766"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dénosumab",
"alternateName": "Denosumab",
"url": "https://questionsmedicales.fr/mesh/D000069448",
"about": {
"@type": "MedicalCondition",
"name": "Dénosumab",
"code": {
"@type": "MedicalCode",
"code": "D000069448",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.782"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gemtuzumab",
"alternateName": "Gemtuzumab",
"url": "https://questionsmedicales.fr/mesh/D000079982",
"about": {
"@type": "MedicalCondition",
"name": "Gemtuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000079982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inotuzumab ozogamicine",
"alternateName": "Inotuzumab Ozogamicin",
"url": "https://questionsmedicales.fr/mesh/D000080045",
"about": {
"@type": "MedicalCondition",
"name": "Inotuzumab ozogamicine",
"code": {
"@type": "MedicalCode",
"code": "D000080045",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.794"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ipilimumab",
"alternateName": "Ipilimumab",
"url": "https://questionsmedicales.fr/mesh/D000074324",
"about": {
"@type": "MedicalCondition",
"name": "Ipilimumab",
"code": {
"@type": "MedicalCode",
"code": "D000074324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.798"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Natalizumab",
"alternateName": "Natalizumab",
"url": "https://questionsmedicales.fr/mesh/D000069442",
"about": {
"@type": "MedicalCondition",
"name": "Natalizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nivolumab",
"alternateName": "Nivolumab",
"url": "https://questionsmedicales.fr/mesh/D000077594",
"about": {
"@type": "MedicalCondition",
"name": "Nivolumab",
"code": {
"@type": "MedicalCode",
"code": "D000077594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.829"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Omalizumab",
"alternateName": "Omalizumab",
"url": "https://questionsmedicales.fr/mesh/D000069444",
"about": {
"@type": "MedicalCondition",
"name": "Omalizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069444",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Palivizumab",
"alternateName": "Palivizumab",
"url": "https://questionsmedicales.fr/mesh/D000069455",
"about": {
"@type": "MedicalCondition",
"name": "Palivizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069455",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Panitumumab",
"alternateName": "Panitumumab",
"url": "https://questionsmedicales.fr/mesh/D000077544",
"about": {
"@type": "MedicalCondition",
"name": "Panitumumab",
"code": {
"@type": "MedicalCode",
"code": "D000077544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.864"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ranibizumab",
"alternateName": "Ranibizumab",
"url": "https://questionsmedicales.fr/mesh/D000069579",
"about": {
"@type": "MedicalCondition",
"name": "Ranibizumab",
"code": {
"@type": "MedicalCode",
"code": "D000069579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.868"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trastuzumab",
"alternateName": "Trastuzumab",
"url": "https://questionsmedicales.fr/mesh/D000068878",
"about": {
"@type": "MedicalCondition",
"name": "Trastuzumab",
"code": {
"@type": "MedicalCode",
"code": "D000068878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ado-trastuzumab emtansine",
"alternateName": "Ado-Trastuzumab Emtansine",
"url": "https://questionsmedicales.fr/mesh/D000080044",
"about": {
"@type": "MedicalCondition",
"name": "Ado-trastuzumab emtansine",
"code": {
"@type": "MedicalCode",
"code": "D000080044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ado-trastuzumab emtansine",
"alternateName": "Ado-Trastuzumab Emtansine",
"url": "https://questionsmedicales.fr/mesh/D000080044",
"about": {
"@type": "MedicalCondition",
"name": "Ado-trastuzumab emtansine",
"code": {
"@type": "MedicalCode",
"code": "D000080044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.875.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ustékinumab",
"alternateName": "Ustekinumab",
"url": "https://questionsmedicales.fr/mesh/D000069549",
"about": {
"@type": "MedicalCondition",
"name": "Ustékinumab",
"code": {
"@type": "MedicalCode",
"code": "D000069549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.200.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps monoclonaux d'origine murine",
"alternateName": "Antibodies, Monoclonal, Murine-Derived",
"url": "https://questionsmedicales.fr/mesh/D058846",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps monoclonaux d'origine murine",
"code": {
"@type": "MedicalCode",
"code": "D058846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.284"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rituximab",
"alternateName": "Rituximab",
"url": "https://questionsmedicales.fr/mesh/D000069283",
"about": {
"@type": "MedicalCondition",
"name": "Rituximab",
"code": {
"@type": "MedicalCode",
"code": "D000069283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.284.785"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Rituximab",
"alternateName": "Rituximab",
"url": "https://questionsmedicales.fr/mesh/D000069283",
"about": {
"@type": "MedicalCondition",
"name": "Rituximab",
"code": {
"@type": "MedicalCode",
"code": "D000069283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.284.785"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Infliximab",
"alternateName": "Infliximab",
"url": "https://questionsmedicales.fr/mesh/D000069285",
"about": {
"@type": "MedicalCondition",
"name": "Infliximab",
"code": {
"@type": "MedicalCode",
"code": "D000069285",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.224.642"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antitumoraux",
"alternateName": "Antibodies, Neoplasm",
"url": "https://questionsmedicales.fr/mesh/D000912",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antitumoraux",
"code": {
"@type": "MedicalCode",
"code": "D000912",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.240"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps neutralisants",
"alternateName": "Antibodies, Neutralizing",
"url": "https://questionsmedicales.fr/mesh/D057134",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps neutralisants",
"code": {
"@type": "MedicalCode",
"code": "D057134",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.244"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps neutralisants à large spectre",
"alternateName": "Broadly Neutralizing Antibodies",
"url": "https://questionsmedicales.fr/mesh/D000080908",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps neutralisants à large spectre",
"code": {
"@type": "MedicalCode",
"code": "D000080908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.244.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps phospho-spécifiques",
"alternateName": "Antibodies, Phospho-Specific",
"url": "https://questionsmedicales.fr/mesh/D045163",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps phospho-spécifiques",
"code": {
"@type": "MedicalCode",
"code": "D045163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.248"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antiprotozoaires",
"alternateName": "Antibodies, Protozoan",
"url": "https://questionsmedicales.fr/mesh/D000913",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antiprotozoaires",
"code": {
"@type": "MedicalCode",
"code": "D000913",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.252"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antiviraux",
"alternateName": "Antibodies, Viral",
"url": "https://questionsmedicales.fr/mesh/D000914",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antiviraux",
"code": {
"@type": "MedicalCode",
"code": "D000914",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps antideltarétrovirus",
"alternateName": "Deltaretrovirus Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015480",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antideltarétrovirus",
"code": {
"@type": "MedicalCode",
"code": "D015480",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-VIH",
"alternateName": "HIV Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015483",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-VIH",
"code": {
"@type": "MedicalCode",
"code": "D015483",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.440"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-HTLVI",
"alternateName": "HTLV-I Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015481",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-HTLVI",
"code": {
"@type": "MedicalCode",
"code": "D015481",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-HTLVII",
"alternateName": "HTLV-II Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015482",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-HTLVII",
"code": {
"@type": "MedicalCode",
"code": "D015482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-VIH",
"alternateName": "HIV Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015483",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-VIH",
"code": {
"@type": "MedicalCode",
"code": "D015483",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.440"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-HTLVI",
"alternateName": "HTLV-I Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015481",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-HTLVI",
"code": {
"@type": "MedicalCode",
"code": "D015481",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-HTLVII",
"alternateName": "HTLV-II Antibodies",
"url": "https://questionsmedicales.fr/mesh/D015482",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-HTLVII",
"code": {
"@type": "MedicalCode",
"code": "D015482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.150.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite",
"alternateName": "Hepatitis Antibodies",
"url": "https://questionsmedicales.fr/mesh/D006508",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite",
"code": {
"@type": "MedicalCode",
"code": "D006508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite A",
"alternateName": "Hepatitis A Antibodies",
"url": "https://questionsmedicales.fr/mesh/D035922",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D035922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.251"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite B",
"alternateName": "Hepatitis B Antibodies",
"url": "https://questionsmedicales.fr/mesh/D006510",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D006510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.504"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite C",
"alternateName": "Hepatitis C Antibodies",
"url": "https://questionsmedicales.fr/mesh/D018937",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite C",
"code": {
"@type": "MedicalCode",
"code": "D018937",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite A",
"alternateName": "Hepatitis A Antibodies",
"url": "https://questionsmedicales.fr/mesh/D035922",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D035922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.251"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite B",
"alternateName": "Hepatitis B Antibodies",
"url": "https://questionsmedicales.fr/mesh/D006510",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D006510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.504"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps de l'hépatite C",
"alternateName": "Hepatitis C Antibodies",
"url": "https://questionsmedicales.fr/mesh/D018937",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps de l'hépatite C",
"code": {
"@type": "MedicalCode",
"code": "D018937",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.254.450.510"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Autoanticorps",
"alternateName": "Autoantibodies",
"url": "https://questionsmedicales.fr/mesh/D001323",
"about": {
"@type": "MedicalCondition",
"name": "Autoanticorps",
"code": {
"@type": "MedicalCode",
"code": "D001323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-protéines citrullinées",
"alternateName": "Anti-Citrullinated Protein Antibodies",
"url": "https://questionsmedicales.fr/mesh/D000075422",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-protéines citrullinées",
"code": {
"@type": "MedicalCode",
"code": "D000075422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.095"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antinucléaires",
"alternateName": "Antibodies, Antinuclear",
"url": "https://questionsmedicales.fr/mesh/D000974",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antinucléaires",
"code": {
"@type": "MedicalCode",
"code": "D000974",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.204"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antiphospholipides",
"alternateName": "Antibodies, Antiphospholipid",
"url": "https://questionsmedicales.fr/mesh/D017152",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antiphospholipides",
"code": {
"@type": "MedicalCode",
"code": "D017152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anticardiolipines",
"alternateName": "Antibodies, Anticardiolipin",
"url": "https://questionsmedicales.fr/mesh/D017153",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anticardiolipines",
"code": {
"@type": "MedicalCode",
"code": "D017153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anticardiolipines",
"alternateName": "Antibodies, Anticardiolipin",
"url": "https://questionsmedicales.fr/mesh/D017153",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anticardiolipines",
"code": {
"@type": "MedicalCode",
"code": "D017153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur néphritique C3",
"alternateName": "Complement C3 Nephritic Factor",
"url": "https://questionsmedicales.fr/mesh/D003178",
"about": {
"@type": "MedicalCondition",
"name": "Facteur néphritique C3",
"code": {
"@type": "MedicalCode",
"code": "D003178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoconglutinines",
"alternateName": "Immunoconglutinins",
"url": "https://questionsmedicales.fr/mesh/D037561",
"about": {
"@type": "MedicalCondition",
"name": "Immunoconglutinines",
"code": {
"@type": "MedicalCode",
"code": "D037561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobulines thyréostimulantes",
"alternateName": "Immunoglobulins, Thyroid-Stimulating",
"url": "https://questionsmedicales.fr/mesh/D018828",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines thyréostimulantes",
"code": {
"@type": "MedicalCode",
"code": "D018828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.480"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur rhumatoïde",
"alternateName": "Rheumatoid Factor",
"url": "https://questionsmedicales.fr/mesh/D012217",
"about": {
"@type": "MedicalCondition",
"name": "Facteur rhumatoïde",
"code": {
"@type": "MedicalCode",
"code": "D012217",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.732"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Abatacept",
"alternateName": "Abatacept",
"url": "https://questionsmedicales.fr/mesh/D000069594",
"about": {
"@type": "MedicalCondition",
"name": "Abatacept",
"code": {
"@type": "MedicalCode",
"code": "D000069594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.580.225"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Isotypes des immunoglobulines",
"alternateName": "Immunoglobulin Isotypes",
"url": "https://questionsmedicales.fr/mesh/D007132",
"about": {
"@type": "MedicalCondition",
"name": "Isotypes des immunoglobulines",
"code": {
"@type": "MedicalCode",
"code": "D007132",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline A",
"alternateName": "Immunoglobulin A",
"url": "https://questionsmedicales.fr/mesh/D007070",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A",
"code": {
"@type": "MedicalCode",
"code": "D007070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.026"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline A sécrétoire",
"alternateName": "Immunoglobulin A, Secretory",
"url": "https://questionsmedicales.fr/mesh/D007071",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A sécrétoire",
"code": {
"@type": "MedicalCode",
"code": "D007071",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.026.030"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline A sécrétoire",
"alternateName": "Immunoglobulin A, Secretory",
"url": "https://questionsmedicales.fr/mesh/D007071",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline A sécrétoire",
"code": {
"@type": "MedicalCode",
"code": "D007071",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.026.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline D",
"alternateName": "Immunoglobulin D",
"url": "https://questionsmedicales.fr/mesh/D007072",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline D",
"code": {
"@type": "MedicalCode",
"code": "D007072",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.251"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline E",
"alternateName": "Immunoglobulin E",
"url": "https://questionsmedicales.fr/mesh/D007073",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline E",
"code": {
"@type": "MedicalCode",
"code": "D007073",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.312"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline G",
"alternateName": "Immunoglobulin G",
"url": "https://questionsmedicales.fr/mesh/D007074",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline G",
"code": {
"@type": "MedicalCode",
"code": "D007074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "LATS",
"alternateName": "Long-Acting Thyroid Stimulator",
"url": "https://questionsmedicales.fr/mesh/D008135",
"about": {
"@type": "MedicalCondition",
"name": "LATS",
"code": {
"@type": "MedicalCode",
"code": "D008135",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Muromonab-CD3",
"alternateName": "Muromonab-CD3",
"url": "https://questionsmedicales.fr/mesh/D016853",
"about": {
"@type": "MedicalCondition",
"name": "Muromonab-CD3",
"code": {
"@type": "MedicalCode",
"code": "D016853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline Rh",
"alternateName": "Rho(D) Immune Globulin",
"url": "https://questionsmedicales.fr/mesh/D018029",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline Rh",
"code": {
"@type": "MedicalCode",
"code": "D018029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "LATS",
"alternateName": "Long-Acting Thyroid Stimulator",
"url": "https://questionsmedicales.fr/mesh/D008135",
"about": {
"@type": "MedicalCondition",
"name": "LATS",
"code": {
"@type": "MedicalCode",
"code": "D008135",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Muromonab-CD3",
"alternateName": "Muromonab-CD3",
"url": "https://questionsmedicales.fr/mesh/D016853",
"about": {
"@type": "MedicalCondition",
"name": "Muromonab-CD3",
"code": {
"@type": "MedicalCode",
"code": "D016853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline Rh",
"alternateName": "Rho(D) Immune Globulin",
"url": "https://questionsmedicales.fr/mesh/D018029",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline Rh",
"code": {
"@type": "MedicalCode",
"code": "D018029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.393.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobuline M",
"alternateName": "Immunoglobulin M",
"url": "https://questionsmedicales.fr/mesh/D007075",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobuline M",
"code": {
"@type": "MedicalCode",
"code": "D007075",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.619.574"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobulines par voie veineuse",
"alternateName": "Immunoglobulins, Intravenous",
"url": "https://questionsmedicales.fr/mesh/D016756",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines par voie veineuse",
"code": {
"@type": "MedicalCode",
"code": "D016756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-insuline",
"alternateName": "Insulin Antibodies",
"url": "https://questionsmedicales.fr/mesh/D007330",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-insuline",
"code": {
"@type": "MedicalCode",
"code": "D007330",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.656"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Alloanticorps",
"alternateName": "Isoantibodies",
"url": "https://questionsmedicales.fr/mesh/D007518",
"about": {
"@type": "MedicalCondition",
"name": "Alloanticorps",
"code": {
"@type": "MedicalCode",
"code": "D007518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.664"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Planticorps",
"alternateName": "Plantibodies",
"url": "https://questionsmedicales.fr/mesh/D046549",
"about": {
"@type": "MedicalCondition",
"name": "Planticorps",
"code": {
"@type": "MedicalCode",
"code": "D046549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.820"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Précipitines",
"alternateName": "Precipitins",
"url": "https://questionsmedicales.fr/mesh/D011234",
"about": {
"@type": "MedicalCondition",
"name": "Précipitines",
"code": {
"@type": "MedicalCode",
"code": "D011234",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.837"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Réagines",
"alternateName": "Reagins",
"url": "https://questionsmedicales.fr/mesh/D011935",
"about": {
"@type": "MedicalCondition",
"name": "Réagines",
"code": {
"@type": "MedicalCode",
"code": "D011935",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.890"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Anticorps",
"alternateName": "Antibodies",
"code": {
"@type": "MedicalCode",
"code": "D000906",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anita Bandrowski",
"url": "https://questionsmedicales.fr/author/Anita%20Bandrowski",
"affiliation": {
"@type": "Organization",
"name": "Center for Research in Biological Systems, University of California , La Jolla, CA, USA."
}
},
{
"@type": "Person",
"name": "Sophana Chea",
"url": "https://questionsmedicales.fr/author/Sophana%20Chea",
"affiliation": {
"@type": "Organization",
"name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia."
}
},
{
"@type": "Person",
"name": "Laura Willen",
"url": "https://questionsmedicales.fr/author/Laura%20Willen",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States."
}
},
{
"@type": "Person",
"name": "Sreynik Nhek",
"url": "https://questionsmedicales.fr/author/Sreynik%20Nhek",
"affiliation": {
"@type": "Organization",
"name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia."
}
},
{
"@type": "Person",
"name": "Piseth Ly",
"url": "https://questionsmedicales.fr/author/Piseth%20Ly",
"affiliation": {
"@type": "Organization",
"name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36651430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/acb371205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.",
"datePublished": "2024-10-20",
"url": "https://questionsmedicales.fr/article/39428439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-76355-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37271051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107624"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03531-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anticorps - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anticorps",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anticorps",
"description": "Comment détecte-t-on les anticorps dans le sang ?\nQuels tests sont utilisés pour les anticorps spécifiques ?\nLes anticorps peuvent-ils indiquer une infection ?\nQu'est-ce qu'un titre d'anticorps ?\nLes anticorps peuvent-ils être détectés chez les nouveau-nés ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anticorps",
"description": "Quels symptômes indiquent une réponse immunitaire ?\nLes anticorps causent-ils des symptômes ?\nComment les anticorps affectent-ils les allergies ?\nLes anticorps peuvent-ils causer des maladies auto-immunes ?\nQuels anticorps sont liés aux infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anticorps",
"description": "Comment les vaccins stimulent-ils la production d'anticorps ?\nLes anticorps peuvent-ils être transférés par le lait maternel ?\nComment maintenir un système immunitaire fort ?\nLes anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?\nLes anticorps sont-ils efficaces contre toutes les infections ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anticorps",
"description": "Comment les anticorps sont-ils utilisés en thérapie ?\nLes anticorps peuvent-ils être administrés par injection ?\nQu'est-ce que l'immunothérapie par anticorps ?\nLes anticorps peuvent-ils être utilisés pour prévenir des maladies ?\nQuels sont les effets secondaires des traitements par anticorps ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anticorps",
"description": "Quels sont les risques d'une surproduction d'anticorps ?\nLes anticorps peuvent-ils causer des réactions allergiques ?\nQuelles complications peuvent survenir avec des anticorps monoclonaux ?\nLes anticorps peuvent-ils interférer avec d'autres traitements ?\nQuelles sont les complications des maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anticorps",
"description": "Quels facteurs augmentent le risque de maladies auto-immunes ?\nLe stress influence-t-il la production d'anticorps ?\nL'âge influence-t-il la réponse des anticorps ?\nLes infections antérieures affectent-elles la production d'anticorps ?\nLes habitudes alimentaires influencent-elles les anticorps ?",
"url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les anticorps dans le sang ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests sérologiques comme l'ELISA pour mesurer les anticorps."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les anticorps spécifiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'immunofluorescence ou les tests d'agglutination sont utilisés."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils indiquer une infection ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence d'anticorps spécifiques peut indiquer une infection antérieure."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un titre d'anticorps ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une mesure de la concentration d'anticorps dans le sang, indiquant l'immunité."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils être détectés chez les nouveau-nés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticorps maternels peuvent être détectés chez les nouveau-nés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réponse immunitaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, et inflammation peuvent indiquer une réponse immunitaire active."
}
},
{
"@type": "Question",
"name": "Les anticorps causent-ils des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ce sont les maladies ou infections que les anticorps combattent qui causent des symptômes."
}
},
{
"@type": "Question",
"name": "Comment les anticorps affectent-ils les allergies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticorps IgE sont impliqués dans les réactions allergiques, provoquant des symptômes."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils causer des maladies auto-immunes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticorps peuvent attaquer les tissus sains, entraînant des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels anticorps sont liés aux infections virales ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticorps IgM et IgG sont souvent associés aux infections virales."
}
},
{
"@type": "Question",
"name": "Comment les vaccins stimulent-ils la production d'anticorps ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins introduisent des antigènes, entraînant la production d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils être transférés par le lait maternel ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticorps maternels sont transférés au bébé par le lait maternel, offrant une protection."
}
},
{
"@type": "Question",
"name": "Comment maintenir un système immunitaire fort ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice et le sommeil aident à maintenir un système immunitaire fort."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements par anticorps monoclonaux sont utilisés pour prévenir les formes graves du COVID-19."
}
},
{
"@type": "Question",
"name": "Les anticorps sont-ils efficaces contre toutes les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité dépend du type d'infection et de la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Comment les anticorps sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps monoclonaux sont utilisés pour traiter diverses maladies, y compris le cancer."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils être administrés par injection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticorps peuvent être administrés par injection pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'immunothérapie par anticorps ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement qui utilise des anticorps pour renforcer la réponse immunitaire contre le cancer."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils être utilisés pour prévenir des maladies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticorps spécifiques peuvent être administrés pour prévenir certaines infections."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements par anticorps ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions allergiques et des infections."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surproduction d'anticorps ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner des maladies auto-immunes ou des allergies graves."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils causer des réactions allergiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains anticorps peuvent provoquer des réactions allergiques en réponse à des allergènes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anticorps monoclonaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections, des réactions allergiques et des effets secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils interférer avec d'autres traitements ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains anticorps peuvent interagir avec d'autres médicaments, affectant leur efficacité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des maladies auto-immunes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des dommages aux organes, des infections et une qualité de vie réduite."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de maladies auto-immunes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et hormonaux peuvent augmenter ce risque."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la production d'anticorps ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la réponse immunitaire et la production d'anticorps."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la réponse des anticorps ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la réponse des anticorps peut diminuer avec l'âge, rendant les personnes âgées plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les infections antérieures affectent-elles la production d'anticorps ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections antérieures peuvent influencer la mémoire immunitaire et la production d'anticorps."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les anticorps ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la production d'anticorps et la santé immunitaire."
}
}
]
}
]
}
└─
Anticorps anti-idiotypiques
Antibodies, Anti-Idiotypic
D000888
-
D12.776.377.715.548.114.071
└─
Anticorps anti-archéens
Antibodies, Archaeal
D019844
-
D12.776.377.715.548.114.107
└─
Anticorps antibactériens
Antibodies, Bacterial
D000907
-
D12.776.377.715.548.114.125
└─
Anticorps bispécifiques
Antibodies, Bispecific
D018033
-
D12.776.377.715.548.114.134
└─
Anticorps bloquants
Antibodies, Blocking
D019138
-
D12.776.377.715.548.114.143
└─
Anticorps catalytiques
Antibodies, Catalytic
D017151
-
D12.776.377.715.548.114.167
└─
Anticorps antifongiques
Antibodies, Fungal
D000908
-
D12.776.377.715.548.114.179
└─
Anticorps antihelminthe
Antibodies, Helminth
D000909
-
D12.776.377.715.548.114.185
└─
Anticorps hétérophiles
Antibodies, Heterophile
D000910
-
D12.776.377.715.548.114.191
└─
Anticorps monoclonaux
Antibodies, Monoclonal
D000911
-
D12.776.377.715.548.114.224
└─
Anticorps antitumoraux
Antibodies, Neoplasm
D000912
-
D12.776.377.715.548.114.240
└─
Anticorps neutralisants
Antibodies, Neutralizing
D057134
-
D12.776.377.715.548.114.244
└─
Anticorps phospho-spécifiques
Antibodies, Phospho-Specific
D045163
-
D12.776.377.715.548.114.248
└─
Anticorps antiprotozoaires
Antibodies, Protozoan
D000913
-
D12.776.377.715.548.114.252
└─
Anticorps antiviraux
Antibodies, Viral
D000914
-
D12.776.377.715.548.114.254
└─
Autoanticorps
Autoantibodies
D001323
-
D12.776.377.715.548.114.323
└─
Isotypes des immunoglobulines
Immunoglobulin Isotypes
D007132
-
D12.776.377.715.548.114.619
└─
Immunoglobulines par voie veineuse
Immunoglobulins, Intravenous
D016756
-
D12.776.377.715.548.114.632
└─
Anticorps anti-insuline
Insulin Antibodies
D007330
-
D12.776.377.715.548.114.656
└─
Alloanticorps
Isoantibodies
D007518
-
D12.776.377.715.548.114.664
└─
Planticorps
Plantibodies
D046549
-
D12.776.377.715.548.114.820
└─
Précipitines
Precipitins
D011234
-
D12.776.377.715.548.114.837
└─
Réagines
Reagins
D011935
-
D12.776.377.715.548.114.890
└─└─
Antistreptolysine
Antistreptolysin
D000989
-
D12.776.377.715.548.114.125.288
└─└─
Anticorps monoclonaux humanisés
Antibodies, Monoclonal, Humanized
D061067
-
D12.776.377.715.548.114.224.200
└─└─
Anticorps monoclonaux d'origine murine
Antibodies, Monoclonal, Murine-Derived
D058846
-
D12.776.377.715.548.114.224.284
└─└─
Infliximab
Infliximab
D000069285
-
D12.776.377.715.548.114.224.642
└─└─
Anticorps neutralisants à large spectre
Broadly Neutralizing Antibodies
D000080908
-
D12.776.377.715.548.114.244.500
└─└─
Anticorps antideltarétrovirus
Deltaretrovirus Antibodies
D015480
-
D12.776.377.715.548.114.254.150
└─└─
Anticorps de l'hépatite
Hepatitis Antibodies
D006508
-
D12.776.377.715.548.114.254.450
└─└─
Anticorps anti-protéines citrullinées
Anti-Citrullinated Protein Antibodies
D000075422
-
D12.776.377.715.548.114.323.095
└─└─
Anticorps antinucléaires
Antibodies, Antinuclear
D000974
-
D12.776.377.715.548.114.323.204
└─└─
Anticorps antiphospholipides
Antibodies, Antiphospholipid
D017152
-
D12.776.377.715.548.114.323.210
└─└─
Facteur néphritique C3
Complement C3 Nephritic Factor
D003178
-
D12.776.377.715.548.114.323.300
└─└─
Immunoconglutinines
Immunoconglutinins
D037561
-
D12.776.377.715.548.114.323.390
└─└─
Immunoglobulines thyréostimulantes
Immunoglobulins, Thyroid-Stimulating
D018828
-
D12.776.377.715.548.114.323.480
└─└─
Facteur rhumatoïde
Rheumatoid Factor
D012217
-
D12.776.377.715.548.114.323.732
└─└─
Abatacept
Abatacept
D000069594
-
D12.776.377.715.548.114.580.225
└─└─
Immunoglobuline A
Immunoglobulin A
D007070
-
D12.776.377.715.548.114.619.026
└─└─
Immunoglobuline D
Immunoglobulin D
D007072
-
D12.776.377.715.548.114.619.251
└─└─
Immunoglobuline E
Immunoglobulin E
D007073
-
D12.776.377.715.548.114.619.312
└─└─
Immunoglobuline G
Immunoglobulin G
D007074
-
D12.776.377.715.548.114.619.393
└─└─
Immunoglobuline M
Immunoglobulin M
D007075
-
D12.776.377.715.548.114.619.574
└─└─└─
Adalimumab
Adalimumab
D000068879
-
D12.776.377.715.548.114.224.200.250
└─└─└─
Alemtuzumab
Alemtuzumab
D000074323
-
D12.776.377.715.548.114.224.200.375
└─└─└─
Basiliximab
Basiliximab
D000077552
-
D12.776.377.715.548.114.224.200.407
└─└─└─
Bévacizumab
Bevacizumab
D000068258
-
D12.776.377.715.548.114.224.200.438
└─└─└─
Brentuximab védotine
Brentuximab Vedotin
D000079963
-
D12.776.377.715.548.114.224.200.469
└─└─└─
Cétuximab
Cetuximab
D000068818
-
D12.776.377.715.548.114.224.200.750
└─└─└─
Daclizumab
Daclizumab
D000077561
-
D12.776.377.715.548.114.224.200.766
└─└─└─
Dénosumab
Denosumab
D000069448
-
D12.776.377.715.548.114.224.200.782
└─└─└─
Gemtuzumab
Gemtuzumab
D000079982
-
D12.776.377.715.548.114.224.200.790
└─└─└─
Inotuzumab ozogamicine
Inotuzumab Ozogamicin
D000080045
-
D12.776.377.715.548.114.224.200.794
└─└─└─
Ipilimumab
Ipilimumab
D000074324
-
D12.776.377.715.548.114.224.200.798
└─└─└─
Natalizumab
Natalizumab
D000069442
-
D12.776.377.715.548.114.224.200.813
└─└─└─
Nivolumab
Nivolumab
D000077594
-
D12.776.377.715.548.114.224.200.829
└─└─└─
Omalizumab
Omalizumab
D000069444
-
D12.776.377.715.548.114.224.200.844
└─└─└─
Palivizumab
Palivizumab
D000069455
-
D12.776.377.715.548.114.224.200.860
└─└─└─
Panitumumab
Panitumumab
D000077544
-
D12.776.377.715.548.114.224.200.864
└─└─└─
Ranibizumab
Ranibizumab
D000069579
-
D12.776.377.715.548.114.224.200.868
└─└─└─
Trastuzumab
Trastuzumab
D000068878
-
D12.776.377.715.548.114.224.200.875
└─└─└─
Ustékinumab
Ustekinumab
D000069549
-
D12.776.377.715.548.114.224.200.937
└─└─└─
Rituximab
Rituximab
D000069283
-
D12.776.377.715.548.114.224.284.785
└─└─└─
Anticorps anti-VIH
HIV Antibodies
D015483
-
D12.776.377.715.548.114.254.150.440
└─└─└─
Anticorps anti-HTLVI
HTLV-I Antibodies
D015481
-
D12.776.377.715.548.114.254.150.500
└─└─└─
Anticorps anti-HTLVII
HTLV-II Antibodies
D015482
-
D12.776.377.715.548.114.254.150.510
└─└─└─
Anticorps de l'hépatite A
Hepatitis A Antibodies
D035922
-
D12.776.377.715.548.114.254.450.251
└─└─└─
Anticorps de l'hépatite B
Hepatitis B Antibodies
D006510
-
D12.776.377.715.548.114.254.450.504
└─└─└─
Anticorps de l'hépatite C
Hepatitis C Antibodies
D018937
-
D12.776.377.715.548.114.254.450.510
└─└─└─
Anticorps anticardiolipines
Antibodies, Anticardiolipin
D017153
-
D12.776.377.715.548.114.323.210.100
└─└─└─
Immunoglobuline A sécrétoire
Immunoglobulin A, Secretory
D007071
-
D12.776.377.715.548.114.619.026.030
└─└─└─
LATS
Long-Acting Thyroid Stimulator
D008135
-
D12.776.377.715.548.114.619.393.550
└─└─└─
Muromonab-CD3
Muromonab-CD3
D016853
-
D12.776.377.715.548.114.619.393.570
└─└─└─
Immunoglobuline Rh
Rho(D) Immune Globulin
D018029
-
D12.776.377.715.548.114.619.393.700
└─└─└─└─
Ado-trastuzumab emtansine
Ado-Trastuzumab Emtansine
D000080044
-
D12.776.377.715.548.114.224.200.875.500
Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat...
Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus....
Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ...
There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
In recent observational studies, a potential link between prostatitis and prostate cancer (PCa) has been hinted at, yet the causality remains ambiguous. In our endeavor to scrutinize the conceivable c...
With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di...
We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ...
An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve...
This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...
To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n...
The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit...
In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ...
A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...
Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o...
PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u...
More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ...
Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga...
Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu...
Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114...
The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...
Purpose: Determine the time-dependent magnitude of intrafraction prostate displacement and a cutoff for the tracking decision. Methods: Nine patients with localized prostate cancer were treated with u...
Apart from other risk factors, chronic inflammation is also associated with the onset of Prostate Cancer (PCa), wherein pathogen infection and tissue microbiome dysbiosis are known to play a major rol...